Andrew M. Dahl serves as Executive at Edwards Lifesciences Corp, where they oversee executive responsibilities. Since joining the company, Andrew M. Dahl has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 13, 2025 involved receiving (via award) 1,160 shares valued at $0.
Andrew M. Dahl currently holds 9,183.07 shares of Edwards Lifesciences Corp (EW), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew M. Dahl has been a net neutral trader of EW stock. They have purchased $0 and sold $0 worth of shares.
Andrew M. Dahl's most recent insider trade was on Nov 13, 2025, when they sold 1,160 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $77.57 |
| Discretionary |
| Sep 13, 2024 | EW | $0 | Award | 2,920 | $N/A | Discretionary |